Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$48.6 - $57.12 $118,875 - $139,715
-2,446 Reduced 2.94%
80,695 $4.51 Million
Q4 2023

Feb 14, 2024

SELL
$43.45 - $53.66 $402,694 - $497,320
-9,268 Reduced 10.03%
83,141 $4.3 Million
Q3 2023

Nov 14, 2023

SELL
$50.12 - $58.87 $56,134 - $65,934
-1,120 Reduced 1.2%
92,409 $4.89 Million
Q2 2023

Aug 14, 2023

BUY
$42.28 - $51.43 $1.33 Million - $1.62 Million
31,440 Added 50.64%
93,529 $4.81 Million
Q1 2023

May 15, 2023

SELL
$40.84 - $58.14 $81,434 - $115,931
-1,994 Reduced 3.11%
62,089 $2.71 Million
Q4 2022

Feb 21, 2023

BUY
$43.88 - $56.16 $25,538 - $32,685
582 Added 0.92%
64,083 $3.56 Million
Q3 2022

Nov 14, 2022

BUY
$48.37 - $66.5 $3 Million - $4.13 Million
62,108 Added 4458.58%
63,501 $3.27 Million
Q1 2021

May 14, 2021

SELL
$62.9 - $82.41 $26,292 - $34,447
-418 Reduced 23.08%
1,393 $103,000
Q2 2020

Aug 11, 2020

BUY
$39.87 - $56.9 $20,373 - $29,075
511 Added 39.31%
1,811 $87,000
Q3 2019

Nov 14, 2019

BUY
$71.74 - $86.35 $93,262 - $112,254
1,300 New
1,300 $96,000
Q4 2018

Feb 15, 2019

SELL
$84.14 - $125.42 $25,242 - $37,626
-300 Closed
0 $0
Q3 2018

Nov 15, 2018

SELL
$101.02 - $130.95 $161,632 - $209,519
-1,600 Reduced 84.21%
300 $37,000
Q2 2018

Aug 14, 2018

BUY
$81.75 - $105.37 $32,700 - $42,148
400 Added 26.67%
1,900 $190,000
Q1 2018

May 11, 2018

SELL
$79.95 - $89.74 $103,935 - $116,662
-1,300 Reduced 46.43%
1,500 $133,000
Q4 2017

Feb 15, 2018

BUY
$71.8 - $88.21 $100,520 - $123,493
1,400 Added 100.0%
2,800 $224,000
Q3 2017

Nov 08, 2017

BUY
$60.32 - $70.06 $84,448 - $98,084
1,400
1,400 $98,000

Others Institutions Holding LIVN

About LivaNova PLC


  • Ticker LIVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,545,700
  • Market Cap $2.5B
  • Description
  • LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...
More about LIVN
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.